Find out more about how GLP-1RAs are associated with a reduced risk of aneurysmal rupture in high-risk patient populations.
Prescriptions of glucagon-like peptide-1 receptor agonists (GLP-1RAs) are associated with a reduced risk of aneurysmal rupture in patients with type 2 diabetes and unruptured intracranial aneurysms, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results